Publications by authors named "Barry M Bernstein"

Claim this Profile
P
Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment.
Amit Khatri, Rajeev M Menon, Thomas C Marbury, Eric J Lawitz, Thomas J Podsadecki, Barry M Bernstein

J Hepatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar safety and efficacy of once- and twice-daily lopinavir/ritonavir tablets in treatment-experienced HIV-1-infected subjects at 48 weeks.
Roberto Zajdenverg, Thomas J Podsadecki, Sharlaa Badal-Faesen, Jaime Andrade-Villanueva, Joseph Gathe, Barry M Bernstein

J Acquir Immune Defic Syndr· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.
Todd T Brown, Grace A McComsey, Martin S King, Roula B Qaqish, Barry M Bernstein

J Acquir Immune Defic Syndr· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine.
Rafael E Campo, Barbara A Da Silva, Laurent Cotte, Joseph C Gathe, Brian Gazzard, Barry M Bernstein

AIDS Res Hum Retroviruses· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.
D William Cameron, Barbara A da Silva, Jose R Arribas, Robert A Myers, Nicholaos C Bellos, Barry M Bernstein

J Infect Dis· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients.
Martin S King, Barry M Bernstein, Sharon L Walmsley, Renslow Sherer, Judith Feinberg

J Infect Dis· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis